Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
1. Novo Nordisk reduces Ozempic price for cash-paying U.S. patients to $499. 2. The new pricing aims to increase access for uninsured Type 2 diabetes patients. 3. Ozempic's original list price was nearly $1,350 per month. 4. Eli Lilly also reduced prices for their similar diabetes treatments. 5. Politicians push for drug pricing reforms, impacting market dynamics.